Sony Award Spotlights Women Revolutionizing Global Healthcare

NEW YORK, NY – February 19, 2026 – Sony Group Corporation and the esteemed scientific journal Nature have named the three recipients of the 2026 Sony Women in Technology Award, celebrating a trio of researchers whose pioneering work is set to redefine the landscape of modern medicine. In its second year, the award provides each winner with a $250,000 prize to accelerate their research, which spans non-invasive tumor destruction, robotic cardiac support, and next-generation health monitoring.

This year’s winners are Dr. Xiwen Gong, who received the early-career prize, and Dr. Ellen Roche and Dr. Zhen Xu, who were both honored in the mid-career category. Their groundbreaking contributions in science and engineering are already addressing some of the world's most pressing health challenges, from cancer to heart disease, underscoring the award's mission to champion technology that drives a positive impact on society.

Innovations Remaking Modern Medicine

The research being honored represents a significant leap forward in medical technology, promising less invasive and more personalized treatments for patients globally. Dr. Zhen Xu, a professor at the University of Michigan, is recognized as a co-inventor of a revolutionary field known as histotripsy. This non-invasive surgical technique uses focused ultrasound waves to mechanically destroy tumors without a single incision. The technology works by creating a tightly controlled field of microbubbles that oscillate and collapse, effectively liquefying targeted tissue while leaving adjacent healthy structures unharmed.

Dr. Xu's work has already achieved a monumental milestone: the histotripsy system for treating liver tumors received FDA approval in late 2023, marking a major clinical victory. Her research is now expanding to address other major global health issues, with potential applications in neurology and cardiovascular medicine. This technology could one day make scalpel-free surgery a reality for a wide range of conditions.

Also honored is Dr. Ellen Roche, an associate professor at MIT, whose interdisciplinary work merges soft robotics, mechanical engineering, and medicine to create novel solutions for cardiac care. Dr. Roche's lab develops implantable and wearable medical devices designed to support and repair the heart. Among her notable inventions is a soft-robotic sleeve that fits over a failing heart, gently twisting and compressing in sync with the natural heartbeat to help it pump blood more effectively. Another of her innovations, a device called Therepi, is a refillable reservoir that adheres to heart tissue for localized, sustained drug delivery, which could revolutionize post-heart attack recovery.

Her research, which also involves building sophisticated robotic simulators to test how devices interact with tissue, aims to develop viable alternatives to heart transplants and improve outcomes for patients with cardiovascular disease.

Receiving the early-career award, Dr. Xiwen Gong of the University of Michigan is being celebrated for her research on solution-processed semiconductors. Her work focuses on designing new, flexible electronic materials at the molecular level. These materials are essential for creating the next generation of wearable sensors and medical devices that can continuously monitor a person’s health. By enabling real-time data collection from the body, Dr. Gong's research paves the way for a future of highly personalized and precise healthcare, where diagnostics and therapeutic interventions are seamlessly integrated into daily life.

Championing Change in a Male-Dominated Field

Beyond celebrating individual achievement, the Sony Women in Technology Award with Nature casts a vital spotlight on the persistent gender gap in science, technology, engineering, and mathematics (STEM). Despite progress, women remain significantly underrepresented, holding less than a third of STEM jobs in the U.S. and Europe. The numbers are even starker in fields like engineering and computer science, where women constitute less than 20% of the workforce. This phenomenon, often called the "leaky pipeline," sees the proportion of women decline at each stage of the academic and professional ladder.

Initiatives like this award are crucial for addressing these disparities not only through financial support but also through recognition and inspiration. The $250,000 grant provides a transformative boost, enabling researchers to expand their teams, purchase specialized equipment, and accelerate the costly process of clinical trials and commercialization. This level of funding can provide the independence needed to pursue high-risk, high-reward ideas that might struggle to secure traditional grants.

"We are honored to celebrate this year's Sony Women in Technology Award with Nature winners and finalists," said Hiroaki Kitano, Chief Technology Fellow of Sony Group Corporation. "These exceptional researchers are pushing the frontiers of science and technology, while inspiring the next generation of women to pursue bold, transformative ideas that benefit both society and the planet."

Magdalena Skipper, Editor in Chief of Nature, echoed this sentiment. "Their excellence and dedication serve as an inspiration for the next generation of women in STEM, and we are proud to celebrate their contributions to making a more inclusive future for research and technology."

A Strategic Partnership for Global Impact

The collaboration between a global technology and entertainment giant and one of the world's most respected scientific publishers is a powerful strategic alliance. For Sony, the award aligns its brand with cutting-edge innovation and corporate social responsibility, demonstrating a commitment to leveraging technology for societal good that extends beyond its consumer products. It reinforces the company’s stated purpose to "fill the world with emotion through the power of creativity and technology."

For Nature Portfolio, the partnership enhances its mission to advance scientific discovery and champion the researchers behind it. By providing a global platform for the winners, the collaboration amplifies the visibility of their work far beyond academic circles, solidifying Nature's role as a central voice in recognizing and disseminating world-changing research.

This initiative reflects a broader trend of corporate-academic partnerships focused on bridging the gap between discovery and real-world application. By directly funding researchers whose work is on the cusp of clinical or societal impact, the award accelerates the translation of knowledge into tangible solutions. The success of this year's winners—from FDA-approved therapies to devices nearing clinical use—demonstrates the immense potential that is unlocked when visionary researchers are given the platform and resources to succeed. Their achievements serve not only as a testament to their individual brilliance but also as a powerful beacon for the next wave of women ready to redefine the boundaries of science and technology.